Bamco Inc. NY Has $11.94 Million Stock Holdings in Ventas, Inc. $VTR

Bamco Inc. NY increased its position in Ventas, Inc. (NYSE:VTR) by 23.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 170,525 shares of the real estate investment trust’s stock after purchasing an additional 32,866 shares during the quarter. Bamco Inc. NY’s holdings in Ventas were worth $11,935,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of VTR. BI Asset Management Fondsmaeglerselskab A S boosted its position in Ventas by 97.7% during the third quarter. BI Asset Management Fondsmaeglerselskab A S now owns 36,713 shares of the real estate investment trust’s stock worth $2,570,000 after purchasing an additional 18,146 shares during the period. Investment Management Corp of Ontario raised its position in shares of Ventas by 1,019.0% in the second quarter. Investment Management Corp of Ontario now owns 133,061 shares of the real estate investment trust’s stock valued at $8,403,000 after purchasing an additional 121,170 shares during the period. Hudson Bay Capital Management LP bought a new position in shares of Ventas in the second quarter valued at about $17,568,000. Aberdeen Group plc lifted its stake in shares of Ventas by 8.3% during the 3rd quarter. Aberdeen Group plc now owns 1,580,923 shares of the real estate investment trust’s stock worth $109,985,000 after buying an additional 120,825 shares during the last quarter. Finally, SCS Capital Management LLC bought a new stake in shares of Ventas during the 2nd quarter worth about $13,788,000. Institutional investors and hedge funds own 94.18% of the company’s stock.

Insider Transactions at Ventas

In related news, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the sale, the executive vice president owned 72,755 shares in the company, valued at approximately $6,184,175. This trade represents a 32.81% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Debra A. Cafaro sold 10,322 shares of Ventas stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the completion of the transaction, the chief executive officer owned 1,114,034 shares in the company, valued at approximately $86,515,880.44. This represents a 0.92% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 86,106 shares of company stock valued at $6,931,397. 1.00% of the stock is owned by corporate insiders.

Ventas Stock Performance

NYSE VTR opened at $86.68 on Monday. The firm has a 50-day moving average price of $81.46 and a two-hundred day moving average price of $76.45. Ventas, Inc. has a 12-month low of $60.15 and a 12-month high of $87.87. The company has a market capitalization of $41.17 billion, a P/E ratio of 160.52, a P/E/G ratio of 2.11 and a beta of 0.73. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03.

Ventas (NYSE:VTR) last released its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). The business had revenue of ($1,229.71) million during the quarter, compared to analyst estimates of $1.53 billion. Ventas had a net margin of 4.31% and a return on equity of 2.09%. The firm’s quarterly revenue was up 21.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.81 earnings per share. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Analysts anticipate that Ventas, Inc. will post 3.4 earnings per share for the current year.

Ventas Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Tuesday, March 31st. This is a positive change from Ventas’s previous quarterly dividend of $0.48. Ventas’s dividend payout ratio is currently 355.56%.

Analyst Ratings Changes

VTR has been the topic of a number of research reports. Wells Fargo & Company upped their price target on shares of Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. Scotiabank boosted their price objective on Ventas from $80.00 to $93.00 and gave the stock a “sector perform” rating in a report on Monday, March 2nd. Jefferies Financial Group reaffirmed a “buy” rating and issued a $93.00 target price on shares of Ventas in a research report on Monday, December 15th. Mizuho increased their target price on Ventas from $87.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 4th. Finally, Morgan Stanley set a $90.00 price target on Ventas in a report on Friday, February 13th. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Ventas currently has a consensus rating of “Moderate Buy” and a consensus target price of $89.00.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.